Derangement of immune responses by myeloid suppressor cells
- 30 October 2003
- journal article
- review article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 53 (2) , 64-72
Abstract
In tumor-bearing mice and cancer patients, tumor progression is often associated with altered hematopoiesis leading to the accumulation of myeloid cells. Extensive studies in preclinical models indicate that these cells share the CD11b and the Gr-1 markers, possess a mixed mature-immature myeloid phenotype, and are responsible for the induction of T-cell dysfunctions, both tumor-specific and nonspecific. Moreover, CD11b+Gr-1+ myeloid cells are described under different unrelated situations associated with temporary impairment of the T-lymphocyte reactivity. This review examines recent findings on the nature, properties, and mechanisms of action of these myeloid suppressor cells (MSCs).Keywords
This publication has 77 references indexed in Scilit:
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1+)CD11b+ immature myeloid suppressor cellsInternational Immunology, 2002
- Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or MelanomaJournal of Experimental Medicine, 2002
- Regulation of T Cell Receptor CD3ζ Chain Expression byl-ArginineJournal of Biological Chemistry, 2002
- Effects of L‐Arginine on the Proliferation of T Lymphocyte SubpopulationsJournal of Parenteral and Enteral Nutrition, 2001
- Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-γ stimulation through a mechanism dependent on endogenous TNF-α and IL-1αEuropean Journal of Immunology, 2000
- Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 2000
- Clinical significance of the determination of angiogenic factorsEuropean Journal of Cancer, 1996
- Vitamin D3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cellsCancer Letters, 1996
- Development of splenic natural suppressor (NS) cells in ehrlich tumor‐bearing miceInternational Journal of Cancer, 1989